1. Home
  2. EYEN vs SGBX Comparison

EYEN vs SGBX Comparison

Compare EYEN & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • SGBX
  • Stock Information
  • Founded
  • EYEN 2014
  • SGBX 2007
  • Country
  • EYEN United States
  • SGBX United States
  • Employees
  • EYEN N/A
  • SGBX N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • EYEN Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • EYEN Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • EYEN 2.0M
  • SGBX 2.4M
  • IPO Year
  • EYEN 2018
  • SGBX 2017
  • Fundamental
  • Price
  • EYEN $1.09
  • SGBX $0.41
  • Analyst Decision
  • EYEN Hold
  • SGBX
  • Analyst Count
  • EYEN 4
  • SGBX 0
  • Target Price
  • EYEN $2.00
  • SGBX N/A
  • AVG Volume (30 Days)
  • EYEN 45.2K
  • SGBX 227.6K
  • Earning Date
  • EYEN 04-15-2025
  • SGBX 05-16-2025
  • Dividend Yield
  • EYEN N/A
  • SGBX N/A
  • EPS Growth
  • EYEN N/A
  • SGBX N/A
  • EPS
  • EYEN N/A
  • SGBX N/A
  • Revenue
  • EYEN $57,336.00
  • SGBX $4,976,618.00
  • Revenue This Year
  • EYEN $7,680.45
  • SGBX $1,628.82
  • Revenue Next Year
  • EYEN $315.38
  • SGBX N/A
  • P/E Ratio
  • EYEN N/A
  • SGBX N/A
  • Revenue Growth
  • EYEN 1414.02
  • SGBX N/A
  • 52 Week Low
  • EYEN $0.85
  • SGBX $0.30
  • 52 Week High
  • EYEN $124.80
  • SGBX $9.30
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 39.27
  • SGBX 47.75
  • Support Level
  • EYEN $1.02
  • SGBX $0.34
  • Resistance Level
  • EYEN $1.18
  • SGBX $0.39
  • Average True Range (ATR)
  • EYEN 0.09
  • SGBX 0.04
  • MACD
  • EYEN 0.06
  • SGBX 0.01
  • Stochastic Oscillator
  • EYEN 72.73
  • SGBX 81.85

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: